REGENAL Trademark

Trademark Overview

On Thursday, March 14, 2024, a trademark application was filed for REGENAL with the United States Patent and Trademark Office. The USPTO has given the REGENAL trademark a serial number of 98450324. The federal status of this trademark filing is OPPOSITION PENDING as of Friday, December 12, 2025. This trademark is owned by Regenall Limited. The REGENAL trademark is filed in the Pharmaceutical Products category with the following description:

Veterinary pharmaceutical preparations for equine use to promote tissue and tendon regeneration.
regenal

General Information

Serial Number98450324
Word MarkREGENAL
Filing DateThursday, March 14, 2024
Status774 - OPPOSITION PENDING
Status DateFriday, December 12, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 25, 2025

Trademark Statements

Goods and ServicesVeterinary pharmaceutical preparations for equine use to promote tissue and tendon regeneration.
Pseudo MarkREGEN ALL

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, March 14, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameRegenall Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressLondon W1G9QJ
GB
Party NameRegenall Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressLondon W1G9QJ
GB

Trademark Events

Event DateEvent Description
Thursday, March 14, 2024NEW APPLICATION ENTERED
Thursday, March 14, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 18, 2024TEAS VOLUNTARY AMENDMENT RECEIVED
Monday, August 26, 2024ASSIGNED TO LIE
Monday, August 26, 2024PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Wednesday, September 25, 2024ASSIGNED TO EXAMINER
Wednesday, October 2, 2024SUSPENSION LETTER WRITTEN
Wednesday, October 2, 2024LETTER OF SUSPENSION E-MAILED
Wednesday, October 2, 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, April 14, 2025SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Tuesday, August 5, 2025SUSPENSION INQUIRY WRITTEN
Tuesday, August 5, 2025INQUIRY TO SUSPENSION E-MAILED
Tuesday, August 5, 2025NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Friday, October 24, 2025TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, October 27, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, October 27, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, October 27, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 19, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 25, 2025PUBLISHED FOR OPPOSITION
Tuesday, November 25, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Friday, December 12, 2025OPPOSITION PAPERS RECEIVED AT TTAB
Friday, December 12, 2025OPPOSITION INSTITUTED NO. 999999

Related Keywords

regenal tissue tendon regeneration promote equine pharmaceutical preparations veterinary